NASDAQ:GEHC

Ge Healthcare Technologies Stock News

Healthcare > Medical - Healthcare Information Services

Buy GEHC

*Your capital is at risk

$62.03

+0.0400 (+0.0645%)

At Close: Jun 03, 2026

GE HealthCare Stock: Hidden Winner Of Alzheimer's Drug Boom

02:08pm, Monday, 21'st Jul 2025

GE HealthCare Technologies is one of the leaders in the healthcare sector, with a strong position in the global molecular imaging market. GE HealthCare's Pharmaceutical Diagnostics segment's EBIT was

3 AI-Driven Medical Device Stocks to Watch in 2025

09:01am, Friday, 11'th Jul 2025

BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.

GE HealthCare to announce second quarter 2025 results on July 30, 2025

08:00am, Monday, 07'th Jul 2025

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its second quarter 2025 financial results before the market opens on Wednesday, July 30, 2025. The GE HealthCare management team wi

GE HealthCare announces cash dividend for second quarter of 2025

08:34am, Tuesday, 01'st Jul 2025

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2025 pay

SNN vs. GEHC: Which Stock Is the Better Value Option?

12:41pm, Wednesday, 25'th Jun 2025

Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew (SNN) and GE HealthCare Technologies (GEHC). But which of these two stocks is more attractive to value investo

GEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded Indications

11:05am, Wednesday, 25'th Jun 2025

GE HealthCare gains FDA nod to expand Vizamyl's use, unlocking new diagnostic and therapy-monitoring capabilities.

FDA Approves Expanded Indications for GE HealthCare's Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer's Patients

02:16pm, Tuesday, 24'th Jun 2025

ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--FDA approves expanded indications for GE HealthCare's Vizamyl PET imaging agent for beta amyloid detection, enabling more precise care for Alzheimer's.

GE HealthCare's Flyrcado Sets New Benchmark in Cardiac PET Imaging

12:00pm, Tuesday, 24'th Jun 2025

GEHC's Flyrcado gains momentum with FDA approval, CMS support, and expanding coverage in cardiac PET imaging.

GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025

08:00am, Monday, 23'rd Jun 2025

CHICAGO--(BUSINESS WIRE)--GE HealthCare's commitment to advancing precision care in cardiology through innovative molecular imaging solutions is on full display at this week's Society of Nuclear Medic

GE Healthcare: Near-Term Margin Headwinds Priced In, Long-Term Growth Driven By New Products And M&As

11:03pm, Saturday, 21'st Jun 2025

GE Healthcare is well-positioned for growth, driven by a strong backlog, product innovation, and potential pent-up demand in China as stimulus funding is deployed. Margin headwinds from tariffs are ex

GE HealthCare drives innovation in theranostics with latest technological advances

08:21am, Saturday, 21'st Jun 2025

CHICAGO--(BUSINESS WIRE)--At this year's Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfo

Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine

12:00pm, Thursday, 19'th Jun 2025

CHICAGO--(BUSINESS WIRE)--Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentio

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by